Department of Urology, Stellenbosch University, Cape Town, South Africa.
BJU Int. 2012 Apr;109(8):1194-7. doi: 10.1111/j.1464-410X.2011.10527.x. Epub 2011 Aug 18.
To compare the clinical features of patients having urinary retention and benign prostatic hyperplasia (BPH) with those having adenocarcinoma of the prostate (ACP) and to evaluate the significance of histological prostatitis.
The clinical data and histopathology reports of patients with retention admitted to Tygerberg Hospital between September 1998 and June 2007 were evaluated. Statistical analysis was performed with Student's t-test, Mann-Whitney test and Fisher's exact test where appropriate and P < 0.05 was considered to indicate statistical significance.
Prostatic histology was available in 405 patients, 204 with BPH and 201 with ACP. Comparing those with BPH and those with ACP showed statistically significant differences in mean age (69.5 vs 71.9 years), serum prostate-specific antigen (PSA) level (18.6 vs 899.5 ng/mL) and histological prostatitis (48 vs 25%) but not duration of catheterization, prostate volume or urinary tract infection (UTI). Comparing those with BPH only and those with BPH plus prostatitis showed significant differences in mean age (71.9 vs 67.1 year) and PSA level (14.6 vs 22.8 ng/mL) but not prostate volume, UTI or duration of catheterization. Comparing those with ACP only and those with ACP plus prostatitis showed significant differences in stage T4 cancer (68.1 vs 35.4%) and PSA level (1123.4 vs 232.4 ng/mL) but not age, prostate volume, UTI or duration of catheterization.
Histological prostatitis was almost twice as common in patients with urinary retention associated with underlying BPH than in patients with ACP, but there was no significant difference in the duration of catheterization, prostatic volume or presence of UTI, suggesting that histological prostatitis more often contributes to the development of retention in patients with underlying BPH than in those with ACP. In patients with BPH, histological prostatitis was associated with urinary retention at a significantly younger age and with higher serum PSA levels. In patients with ACP, histological prostatitis was associated with urinary retention at an earlier stage of cancer.
比较患有尿潴留和良性前列腺增生症(BPH)的患者与患有前列腺腺癌(ACP)的患者的临床特征,并评估组织学前列腺炎的意义。
评估了 1998 年 9 月至 2007 年 6 月期间入住泰格伯格医院的患有潴留的患者的临床数据和组织病理学报告。使用学生 t 检验、Mann-Whitney 检验和 Fisher 确切检验进行统计分析,适当情况下 P<0.05 表示具有统计学意义。
在 405 例患者中,有前列腺组织学检查结果,其中 204 例为 BPH,201 例为 ACP。比较 BPH 患者和 ACP 患者,在平均年龄(69.5 岁 vs 71.9 岁)、血清前列腺特异性抗原(PSA)水平(18.6ng/ml vs 899.5ng/ml)和组织学前列腺炎(48% vs 25%)方面有统计学差异,但在导管留置时间、前列腺体积或尿路感染(UTI)方面无差异。比较单纯 BPH 患者和 BPH 合并前列腺炎患者,在平均年龄(71.9 岁 vs 67.1 岁)和 PSA 水平(14.6ng/ml vs 22.8ng/ml)方面有统计学差异,但在前列腺体积、UTI 或导管留置时间方面无差异。比较单纯 ACP 患者和 ACP 合并前列腺炎患者,在 T4 期癌症(68.1% vs 35.4%)和 PSA 水平(1123.4ng/ml vs 232.4ng/ml)方面有统计学差异,但在年龄、前列腺体积、UTI 或导管留置时间方面无差异。
在与潜在 BPH 相关的尿潴留患者中,组织学前列腺炎的发生率几乎是患有 ACP 的患者的两倍,但在导管留置时间、前列腺体积或尿路感染方面无差异,这表明组织学前列腺炎更常导致潜在 BPH 患者发生潴留,而不是 ACP 患者。在 BPH 患者中,组织学前列腺炎与更年轻的年龄和更高的血清 PSA 水平相关。在 ACP 患者中,组织学前列腺炎与癌症的早期阶段相关。